Twist Bioscience

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Trade Twist Bioscience 24 hours a day, five days a week on Robinhood.

Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.

About TWST

Twist Bioscience Corp. engages in the development of a proprietary semiconductor-based synthetic DNA manufacturing process. It operates through the following geographical segments: Americas, EMEA, and APAC. 

CEO
Emily Marine Leproust
CEOEmily Marine Leproust
Employees
979
Employees979
Headquarters
San Francisco, California
HeadquartersSan Francisco, California
Founded
2013
Founded2013
Employees
979
Employees979

TWST Key Statistics

Market cap
3.54B
Market cap3.54B
Price-Earnings ratio
-42.79
Price-Earnings ratio-42.79
Dividend yield
Dividend yield
Average volume
1.55M
Average volume1.55M
High today
$59.00
High today$59.00
Low today
$56.00
Low today$56.00
Open price
$58.53
Open price$58.53
Volume
1.09M
Volume1.09M
52 Week high
$66.06
52 Week high$66.06
52 Week low
$23.30
52 Week low$23.30

Stock Snapshot

As of today, Twist Bioscience(TWST) shares are valued at $57.51. The company's market cap stands at 3.54B, with a P/E ratio of -42.79.

On 2026-05-08, Twist Bioscience(TWST) stock traded between a low of $56.00 and a high of $59.00. Shares are currently priced at $57.51, which is +2.7% above the low and -2.5% below the high.

The Twist Bioscience(TWST)'s current trading volume is 1.09M, compared to an average daily volume of 1.55M.

During the past year, Twist Bioscience(TWST) stock moved between $23.30 at its lowest and $66.06 at its peak.

During the past year, Twist Bioscience(TWST) stock moved between $23.30 at its lowest and $66.06 at its peak.

TWST News

Simply Wall St 1d
A Look At Twist Bioscience Valuation After Strong Q2 Results And Complex Genes Launch

Twist Bioscience (TWST) is back in the spotlight after reporting fiscal second quarter revenue of US$110.72 million, 19% above the prior year, lifting full year...

A Look At Twist Bioscience Valuation After Strong Q2 Results And Complex Genes Launch
TipRanks 4d
Twist Bioscience announces inducement grants under Nasdaq listing rule

Twist Bioscience (TWST) announced that a total of 115,279 equity awards, consisting of 101,931 restricted stock units and up to 13,348 performance stock units,...

Simply Wall St 4d
Why Twist Bioscience Is Down 7.9% After Wider Losses And New Complex Genes Launch – And What's Next

Twist Bioscience recently reported past second-quarter 2026 results, with sales rising to US$110.72 million from US$92.79 million a year earlier, while net loss...

Why Twist Bioscience Is Down 7.9% After Wider Losses And New Complex Genes Launch – And What's Next

Analyst ratings

100%

of 9 ratings
Buy
100%
Hold
0%
Sell
0%

More TWST News

TipRanks 4d
Twist Bioscience Charts Profitable Path Amid Strong Growth

Twist Bioscience ((TWST)) has held its Q2 earnings call. Read on for the main highlights of the call. Claim 55% Off TipRanks Unlock hedge fund-level data and po...

Benzinga 4d
AI-Driven Demand Boosts Twist Bioscience Sales, But Loss Widens

The life science company reported an adjusted loss of 59 cents, missing the consensus loss of 48 cents. The sales came in at $110.72 million, beating the conse...

AI-Driven Demand Boosts Twist Bioscience Sales, But Loss Widens
TipRanks 5d
Twist Bioscience expands clonal genes portfolio with Complex Genes

Twist Bioscience (TWST) expanded its clonal genes portfolio with the early access launch of Complex Genes. Sequences with complex elements have historically bee...

People also own

Based on the portfolios of people who own TWST. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.